文献速递药疹与重症皮肤不良反应

TNF-α介导的角质形成细胞表达与释放基质金属蛋白酶9:史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症发病机制的推定机制

TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis.
PubMed 文献 · J Invest Dermatol · 2022-12-26

本研究通过RNA测序、免疫组化和细胞实验探讨SJS/TEN中表皮基质金属蛋白酶9(MMP9)的表达及其与TNF-α和依那西普的关系。发现SJS/TEN皮肤表皮MMP9表达显著高于健康对照和非大疱性药疹,SJS/TEN血清可诱导健康皮肤外植体MMP9表达和胶原酶活性,依那西普可减弱该诱导及TNF-α诱导的HaCaT细胞MMP9表达。数据提示表皮MMP9表达和胶原酶活性升高是SJS/TEN的推定致病机制,并受依那西普限制。

要点

  • SJS/TEN皮肤表皮MMP9表达显著高于健康对照和非大疱性药疹。
  • SJS/TEN血清诱导健康皮肤外植体MMP9表达和胶原酶活性,依那西普可减弱。
  • 依那西普可抵消TNF-α诱导的HaCaT细胞MMP9表达。

核心结论

  • 数据提示表皮MMP9表达和胶原酶活性升高是SJS/TEN的推定致病机制,并受依那西普限制。
  • 调节MMP9表达和活性代表据作者所知此前未报告过的SJS/TEN治疗靶点。

研究设计与样本

  • 采用RNA测序识别福尔马林固定石蜡包埋SJS/TEN皮肤活检中上调的转录本。
  • 通过免疫组化评估皮肤活检和暴露于皮肤不良反应患者血清的培养人皮肤外植体中的表皮MMP9表达。
  • 使用HaCaT永生化角质形成细胞系测定TNF-α诱导的MMP9表达和活性及依那西普的抵消作用。

主要发现

  • SJS/TEN皮肤表皮MMP9表达为70.6%,显著高于健康对照皮肤的0%(P=0.0098)和非大疱性皮肤反应的10.7%(P=0.0002)。
  • SJS/TEN血清诱导健康皮肤外植体显著的MMP9表达和胶原酶活性,依那西普可减少该诱导。
  • 依那西普能够抵消HaCaT细胞系中TNF-α诱导的MMP9表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stevens‒Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe cutaneous adverse drug reactions characterized by widespread keratinocyte cell death and epidermal detachment. At present, there is little understanding of how the detachment occurs or how it is abrogated by the TNF-α inhibitor etanercept, an effective SJS/TEN treatment. RNA sequencing was used to identify upregulated transcripts in formalin-fixed paraffin-embedded SJS/TEN skin biopsies. Epidermal matrix metalloproteinase 9 (MMP9) expression was assessed by immunohistochemistry in skin biopsies and cultured human skin explants exposed to serum from patients with cutaneous adverse drug reactions. TNF-α‒induced MMP9 expression and activity and its abrogation by etanercept were determined using the HaCaT immortalized keratinocyte cell line. Epidermal MMP9 expression was significantly higher in SJS/TEN skin (70.6%) than in healthy control skin (0%) (P = 0.0098) and nonbullous skin reactions (10.7%) (P = 0.0002). SJS/TEN serum induced significant MMP9 expression and collagenase activity in healthy skin explants, which was reduced by etanercept. Etanercept was also able to negate the TNF-α‒induced MMP9 expression in the HaCaT cell line. Data suggest that elevated epidermal MMP9 expression and collagenase activity are a putative pathogenic mechanism in SJS/TEN, which is limited by etanercept. Modulation of MMP9 expression and activity represents, to our knowledge, a previously unreported therapeutic target for the treatment of SJS/TEN.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Olsson-Brown A, Yip V, Ogiji ED, et al. TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis. J Invest Dermatol. 2022. PMID: 36581093. doi:10.1016/j.jid.2022.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。